NCT05108038View on ClinicalTrials.gov

A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
GERD
Interventions
DRUG

CKD-382, D860, D027

QD, PO for 7days

Trial Locations (1)

Unknown

RECRUITING

Chungbuk Ntional University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY